- Home
- AUPH vs JBLU Comparison
AUPH vs JBLU Comparison
Compare AUPH & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- JBLU
- Stock Information
- Founded
- AUPH 1993
- JBLU 1998
- Country
- AUPH Canada
- JBLU United States
- Employees
- AUPH N/A
- JBLU N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- AUPH Health Care
- JBLU Consumer Discretionary
- Exchange
- AUPH Nasdaq
- JBLU Nasdaq
- Market Cap
- AUPH 1.6B
- JBLU 1.5B
- IPO Year
- AUPH 1999
- JBLU N/A
- Fundamental
- Price
- AUPH $16.44
- JBLU $4.57
- Analyst Decision
- AUPH Strong Buy
- JBLU Sell
- Analyst Count
- AUPH 3
- JBLU 8
- Target Price
- AUPH $17.67
- JBLU $5.04
- AVG Volume (30 Days)
- AUPH 2.2M
- JBLU 17.6M
- Earning Date
- AUPH 11-04-2025
- JBLU 10-28-2025
- Dividend Yield
- AUPH N/A
- JBLU N/A
- EPS Growth
- AUPH N/A
- JBLU N/A
- EPS
- AUPH 0.55
- JBLU N/A
- Revenue
- AUPH $265,808,000.00
- JBLU $9,095,000,000.00
- Revenue This Year
- AUPH $17.33
- JBLU N/A
- Revenue Next Year
- AUPH $14.31
- JBLU $8.00
- P/E Ratio
- AUPH $29.89
- JBLU N/A
- Revenue Growth
- AUPH 20.62
- JBLU N/A
- 52 Week Low
- AUPH $6.55
- JBLU $3.34
- 52 Week High
- AUPH $16.47
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- AUPH 75.78
- JBLU 58.13
- Support Level
- AUPH $14.94
- JBLU $4.00
- Resistance Level
- AUPH $15.81
- JBLU $4.29
- Average True Range (ATR)
- AUPH 0.61
- JBLU 0.19
- MACD
- AUPH 0.06
- JBLU 0.05
- Stochastic Oscillator
- AUPH 97.97
- JBLU 97.59
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.